Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Jan Vanwelkenhuyzen"'
Autor:
Jan Vanwelkenhuyzen, Eva Van Bos, Siska Van Bruwaene, Karl Lesage, Alex Maes, Sezgin Üstmert, Filip Lavent, Laurence Beels, Henrik Grönberg, Piet Ost, Johan Lindberg, Bram De Laere
Publikováno v:
European Urology Open Science, Vol 53, Iss , Pp 63-66 (2023)
Lutetium-177 prostate-specific membrane antigen radioligands (177Lu-PSMA) are new therapeutic agents for the treatment of metastatic castration-resistant prostate cancer (mCRPC). We evaluated the prognostic value of circulating tumour DNA (ctDNA) pro
Externí odkaz:
https://doaj.org/article/07f84f7603244e0b9d3eee1e8de33ba6
Autor:
Matthew P. Deek, Sofie Verbeke, Piet Ost, Alexander W. Wyatt, Valérie Fonteyne, Nicolaas Lumen, Kim Van der Eecken, Evan W. Warner, Phuoc T. Tran, Bram De Laere, Jo Van Dorpe, Jan Vanwelkenhuyzen, Edmond M. Kwan
Publikováno v:
European urology oncology. 4(6)
Context Multiple studies have reported on the genomic characteristics of metastatic hormone-sensitive prostate cancer (mHSPC). The impact of these findings on prognostication, treatment selection, and clinical trial design remains unclear. Objective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f180d757113fa052289cf0cb9bd57a47
https://pubmed.ncbi.nlm.nih.gov/34857503
https://pubmed.ncbi.nlm.nih.gov/34857503